Search Results - "Giacomini, Arianna"

Refine Results
  1. 1

    Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach by Presta, Marco, Chiodelli, Paola, Giacomini, Arianna, Rusnati, Marco, Ronca, Roberto

    Published in Pharmacology & therapeutics (Oxford) (01-11-2017)
    “…Originally characterized as angiogenic factors, fibroblast growth factors (FGFs) are pleiotropic factors that exert autocrine and paracrine functions on tumor…”
    Get full text
    Journal Article
  2. 2

    The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis by Ronca, Roberto, Giacomini, Arianna, Rusnati, Marco, Presta, Marco

    Published in Expert opinion on therapeutic targets (03-10-2015)
    “…Fibroblast growth factors (FGFs) are endowed with a potent pro-angiogenic activity. Activation of the FGF/FGF receptor (FGFR) system occurs in a variety of…”
    Get more information
    Journal Article
  3. 3

    Future applications of FGF/FGFR inhibitors in cancer by Ghedini, Gaia Cristina, Ronca, Roberto, Presta, Marco, Giacomini, Arianna

    Published in Expert review of anticancer therapy (02-09-2018)
    “…Introduction: Deregulation of the fibroblast growth factor (FGF)/FGF receptor (FGFR) network occurs frequently in tumors due to gene amplification, activating…”
    Get full text
    Journal Article
  4. 4

    Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy by Ronca, Roberto, Giacomini, Arianna, Di Salle, Emanuela, Coltrini, Daniela, Pagano, Katiuscia, Ragona, Laura, Matarazzo, Sara, Rezzola, Sara, Maiolo, Daniele, Torella, Rubben, Moroni, Elisabetta, Mazzieri, Roberta, Escobar, Giulia, Mor, Marco, Colombo, Giorgio, Presta, Marco

    Published in Cancer cell (10-08-2015)
    “…The fibroblast growth factor (FGF)/FGF receptor (FGFR) system plays a crucial role in cancer by affecting tumor growth, angiogenesis, drug resistance, and…”
    Get full text
    Journal Article
  5. 5

    Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease by Righi, Marco, Belleri, Mirella, Presta, Marco, Giacomini, Arianna

    “…We performed a three-dimensional (3D) analysis of the microvascular network of the cerebral cortex of twitcher mice (an authentic model of Krabbe disease)…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma by Annese, Tiziana, Ronca, Roberto, Tamma, Roberto, Giacomini, Arianna, Ruggieri, Simona, Grillo, Elisabetta, Presta, Marco, Ribatti, Domenico

    “…Fibrosarcoma is an aggressive subtype of soft tissue sarcoma categorized in infantile/congenital-type and adult-type. Fibrosarcoma cells and its surrounding…”
    Get full text
    Journal Article
  10. 10

    The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma by Giacomini, Arianna, Taranto, Sara, Gazzaroli, Giorgia, Faletti, Jessica, Capoferri, Davide, Marcheselli, Raffaella, Sciumè, Margherita, Presta, Marco, Sacco, Antonio, Roccaro, Aldo M

    “…Among blood cancers, multiple myeloma (MM) represents the second most common neoplasm and is characterized by the accumulation and proliferation of monoclonal…”
    Get full text
    Journal Article
  11. 11
  12. 12

    FGF-trapping hampers cancer stem-like cells in uveal melanoma by Loda, Alessandra, Calza, Stefano, Giacomini, Arianna, Ravelli, Cosetta, Krishna Chandran, Adwaid Manu, Tobia, Chiara, Tabellini, Giovanna, Parolini, Silvia, Semeraro, Francesco, Ronca, Roberto, Rezzola, Sara

    Published in Cancer cell international (11-05-2023)
    “…Cancer stem-like cells (CSCs) are a subpopulation of tumor cells responsible for tumor initiation, metastasis, chemoresistance, and relapse. Recently, CSCs…”
    Get full text
    Journal Article
  13. 13

    β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease by Belleri, Mirella, Coltrini, Daniela, Righi, Marco, Ravelli, Cosetta, Taranto, Sara, Chiodelli, Paola, Mitola, Stefania, Presta, Marco, Giacomini, Arianna

    “…Krabbe disease (KD) is an autosomal recessive sphingolipidosis caused by the deficiency of the lysosomal hydrolase β-galactosylceramidase (GALC)…”
    Get full text
    Journal Article
  14. 14

    The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination by Turati, Marta, Giacomini, Arianna, Rezzola, Sara, Maccarinelli, Federica, Gazzaroli, Giorgia, Valentino, Sonia, Bottazzi, Barbara, Presta, Marco, Ronca, Roberto

    Published in Experimental hematology & oncology (01-11-2022)
    “…Abstract The lymphatic vascular system represents a major route for dissemination of several solid tumors, including melanoma. Even though the members of the…”
    Get full text
    Journal Article
  15. 15

    The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells by Asperti, Michela, Cantamessa, Luca, Ghidinelli, Simone, Gryzik, Magdalena, Denardo, Andrea, Giacomini, Arianna, Longhi, Giovanna, Fanzani, Alessandro, Arosio, Paolo, Poli, Maura

    Published in Pharmaceuticals (Basel, Switzerland) (02-09-2019)
    “…Ribonucleotide reductase (RR) is the rate-limiting enzyme that controls the deoxynucleotide triphosphate synthesis and it is an important target of cancer…”
    Get full text
    Journal Article
  16. 16

    Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth by Rodrigues, Priscila Fabiana, Matarazzo, Sara, Maccarinelli, Federica, Foglio, Eleonora, Giacomini, Arianna, Silva Nunes, João Paulo, Presta, Marco, Dias, Adriana Abalen Martins, Ronca, Roberto

    Published in Frontiers in oncology (01-11-2018)
    “…Fibrosarcomas are soft tissue mesenchymal tumors originating from transformed fibroblasts. Fibroblast growth factor-2 (FGF2) and its tyrosine-kinase receptors…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    (3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies by Righi, Marco, Giacomini, Arianna, Cleris, Loredana, Carlo-Stella, Carmelo

    Published in PloS one (26-03-2013)
    “…Quantitative characterization of the in vivo effects of vascular-targeted therapies on tumor vessels is hampered by the absence of useful 3D vascular network…”
    Get full text
    Journal Article